Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.

Journal article

Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Journal article

Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15

Purification of African Swine Fever Virus.

Journal article

Shimmon GL. et al, (2022), Methods in molecular biology (Clifton, N.J.), 2503, 179 - 186

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

Journal article

Huang K-YA. et al, (2022), THERANOSTICS, 12, 1 - 17

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.

Journal article

Dejnirattisai W. et al, (2021), Lancet (London, England)

Bacteriophage PRD1 as a nanoscaffold for drug loading.

Journal article

Duyvesteyn HME. et al, (2021), Nanoscale

Sex in Chemsex: Sexual Response, Motivations, and Sober Sex in a Group of Italian Men Who Have Sex With Men With Sexualized Drug Use.

Journal article

Nimbi FM. et al, (2021), The journal of sexual medicine, 18, 1955 - 1969

iNEXT-Discovery and Instruct-ERIC: Integrating High-End Services for Translational Research in Structural Biology.

Journal article

Wienk H. et al, (2021), Journal of visualized experiments : JoVE

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Journal article

Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13

Load More